Close Menu

NEW YORK – Bio-Rad Laboratories yesterday filed another lawsuit accusing 10x Genomics of patent infringement.

The suit, filed in the US District Court for the District of Delaware, alleges that 10x's Next GEM microfluidic chips infringe Bio-Rad's US Patent No. 8,871,444, titled "In vitro evolution in microfluidic systems." Bio-Rad said it exclusively licensed the patent from Harvard University and the UK's Medical Research Council. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

Sponsored by

This webinar features two speakers who will discuss novel computational approaches to optimize sequencing workflows on Oxford Nanopore sequencing platforms.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.